share_log

Esperion Therapeutics Shares Are Trading Higher. The Stock May Be Moving on Continued Strength After Reporting Better-than-expected Q3 Financing Results Yesterday. Also, HC Wainwright & Co. Reiterated a Buy Rating on the Stock.

Benzinga ·  Nov 8 14:01
Esperion Therapeutics Shares Are Trading Higher. The Stock May Be Moving on Continued Strength After Reporting Better-than-expected Q3 Financing Results Yesterday. Also, HC Wainwright & Co. Reiterated a Buy Rating on the Stock.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment